Cargando…

Intranasal Immunization with an Archaeal Lipid Mucosal Vaccine Adjuvant and Delivery Formulation Protects against a Respiratory Pathogen Challenge

Archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) is a safe mucosal adjuvant that elicits long lasting and memory boostable mucosal and systemic immune responses to model antigens such as ovalbumin. In this study, we evaluated the potential of the AMVAD system for eliciting protective imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Girishchandra B., Zhou, Hongyan, Ponce, Amalia, Harris, Greg, Chen, Wangxue
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012068/ https://www.ncbi.nlm.nih.gov/pubmed/21206916 http://dx.doi.org/10.1371/journal.pone.0015574

Ejemplares similares

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)

Acinetobacter baumannii Infection Inhibits Airway Eosinophilia and Lung Pathology in a Mouse Model of Allergic Asthma
por: Qiu, Hongyu, et al.
Publicado: (2011)

Role of Macrophages in Early Host Resistance to Respiratory Acinetobacter baumannii Infection
por: Qiu, Hongyu, et al.
Publicado: (2012)

Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics
por: Fatouh, Ahmed M, et al.
Publicado: (2017)

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
por: Hasegawa, Hideki, et al.
Publicado: (2009)

Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines
por: Yoshino, Naoto, et al.
Publicado: (2023)

Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
por: Anggraeni, Rahmi, et al.
Publicado: (2022)

Lipids of Archaeal Viruses
por: Roine, Elina, et al.
Publicado: (2012)

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
por: Arias, Mauricio A., et al.
Publicado: (2012)

New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan
por: Popescu, Roxana, et al.
Publicado: (2020)

Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery
por: Maher, Rebecca, et al.
Publicado: (2023)

Formulation, High Throughput In Vitro Screening and In Vivo Functional Characterization of Nanoemulsion-Based Intranasal Vaccine Adjuvants
por: Wong, Pamela T., et al.
Publicado: (2015)

The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen
por: Falkeborn, Tina, et al.
Publicado: (2017)

Nano-Encapsulated Melatonin: A Promising Mucosal Adjuvant in Intranasal Immunization against Chronic Experimental T. gondii Infection
por: Said, Doaa E., et al.
Publicado: (2022)

Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice
por: Jangra, Sonia, et al.
Publicado: (2023)

Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder
por: Ball, Jordan P., et al.
Publicado: (2017)

Formulation and kinetic modeling of curcumin loaded intranasal mucoadhesive microemulsion
por: Patel, Mikesh B., et al.
Publicado: (2012)

Cytokines: The Future of Intranasal Vaccine Adjuvants
por: Thompson, Afton L., et al.
Publicado: (2011)

RNA is an Adjuvanticity Mediator for the Lipid-Based Mucosal Adjuvant, Endocine
por: Hayashi, Masayuki, et al.
Publicado: (2016)

Biosynthesis of archaeal membrane ether lipids
por: Jain, Samta, et al.
Publicado: (2014)

Archaeosomes: New Generation of Liposomes Based on Archaeal Lipids for Drug Delivery and Biomedical Applications
por: Santhosh, Poornima Budime, et al.
Publicado: (2022)

A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2012)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

Nano-Encapsulated Antioxidant: Retinoic Acid as a Natural Mucosal Adjuvant for Intranasal Immunization against Chronic Experimental Toxoplasmosis
por: Said, Doaa E., et al.
Publicado: (2023)

Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity
por: Hartwell, Brittany L., et al.
Publicado: (2022)

Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge
por: Mann, Alex J., et al.
Publicado: (2014)

Tailoring Midazolam-Loaded Chitosan Nanoparticulate Formulation for Enhanced Brain Delivery via Intranasal Route
por: Shrestha, Nikesh, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery
por: Nguyen, Thi-Thao-Linh, et al.
Publicado: (2022)

Design and Efficacy of Nanogels Formulations for Intranasal Administration
por: Aderibigbe, Blessing A., et al.
Publicado: (2018)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8(+) T cell responses
por: Si, Youhui, et al.
Publicado: (2018)

Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
por: Nelson, Sean A., et al.
Publicado: (2021)

The Promise and Challenges of Cyclic Dinucleotides as Molecular Adjuvants for Vaccine Development
por: Yan, Hongbin, et al.
Publicado: (2021)

Intranasal administration of cationic liposomes enhanced granulocyte–macrophage colony-stimulating factor expression and this expression is dispensable for mucosal adjuvant activity
por: Tada, Rui, et al.
Publicado: (2018)

Use of PELC/CpG Adjuvant for Intranasal Immunization with Recombinant Hemagglutinin to Develop H7N9 Mucosal Vaccine
por: Chen, Ting-Hsuan, et al.
Publicado: (2020)

Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice
por: Deimel, Lachlan P., et al.
Publicado: (2022)

Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice
por: Ganesan, Shyamala, et al.
Publicado: (2022)

Editorial: Advances in Vaccine Delivery: Adjuvants, Carriers, Formulations, and Routes
por: Skwarczynski, Mariusz
Publicado: (2022)

Thermal Adaptation of the Archaeal and Bacterial Lipid Membranes
por: Koga, Yosuke
Publicado: (2012)

Development of Carbamazepine Nanostructured Lipid Carrier Loaded Thermosensitive Gel for Intranasal Delivery
por: Deshkar, Sanjeevani Shekhar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rdf7i8pspgnts5o5vsjeu0tdri